Immunovant (IMVT) Share-based Compensation (2019 - 2026)
Immunovant (IMVT) reported Share-based Compensation of $13.77 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 25.6% from $18.51 million a year earlier but up 23.6% from the prior quarter.
Immunovant (IMVT) Share-based Compensation (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immunovant's Share-based Compensation came in at $50.99 million, down 6.5% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $55.72 million, up 12.6% from FY2025.
- Share-based Compensation has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 24.2% (FY2021 to FY2026).
- By fiscal year, Share-based Compensation came in at $49.49 million in FY2025 (+20.4%), $41.12 million in FY2024 (+27.3%), $32.3 million in FY2023 (-5.7%) and $34.24 million in FY2022 (+81.9%).
- Five-year quarterly Share-based Compensation spans a low of $7.55 million in fiscal Q4 2023 and a high of $18.51 million in fiscal Q1 2026.
- Year over year, Share-based Compensation gained in six of the last eight quarters, with growth averaging 9.6%.
- The high point for year-over-year Share-based Compensation in five years was fiscal Q2 2022 (growth of 148.8%); the low point was fiscal Q4 2023 (a decline of 36.4%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $11.14 million (Q4 2026), $12.72 million (Q3 2026) and $13.36 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Immunovant | 6.91 Bn | 6.91 Bn | - | 13.77 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.77 Mn |
| Mar 31, 2026 | 11.14 Mn |
| Dec 31, 2025 | 12.72 Mn |
| Sep 30, 2025 | 13.36 Mn |
| Jun 30, 2025 | 18.51 Mn |
| Mar 31, 2025 | 11.69 Mn |
| Dec 31, 2024 | 11.65 Mn |
| Sep 30, 2024 | 12.69 Mn |
| Jun 30, 2024 | 13.46 Mn |
| Mar 31, 2024 | 9.68 Mn |
| Dec 31, 2023 | 10.22 Mn |
| Sep 30, 2023 | 10.53 Mn |
| Jun 30, 2023 | 10.69 Mn |
| Mar 31, 2023 | 7.55 Mn |
| Dec 31, 2022 | 8.91 Mn |
| Sep 30, 2022 | 8.16 Mn |
| Jun 30, 2022 | 7.69 Mn |
| Mar 31, 2022 | 11.86 Mn |
| Dec 31, 2021 | 10.16 Mn |
| Sep 30, 2021 | 8.36 Mn |
Immunovant Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();